Ausgabe 2/2010
Inhalt (30 Artikel)
Efficacy of ixabepilone in ER/PR/HER2-negative (triple-negative) breast cancer
Edith A. Perez, Tejal Patel, Alvaro Moreno-Aspitia
Conflict of interest in economic analyses of aromatase inhibitors in breast cancer: a systematic review
Sekwon Jang, Young Kwang Chae, Tufia Haddad, Navneet S. Majhail
Health disparities in breast cancer: biology meets socioeconomic status
Barbara K. Dunn, Tanya Agurs-Collins, Doris Browne, Ronald Lubet, Karen A. Johnson
Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence
Lyndsay V. Rhodes, Shannon E. Muir, Steven Elliott, Lori M. Guillot, James W. Antoon, Patrice Penfornis, Syreeta L. Tilghman, Virgilio A. Salvo, Juan P. Fonseca, Michelle R. Lacey, Barbara S. Beckman, John A. McLachlan, Brian G. Rowan, Radhika Pochampally, Matthew E. Burow
Clinical evaluation of chemotherapy response predictors developed from breast cancer cell lines
Cornelia Liedtke, Jing Wang, Attila Tordai, William F. Symmans, Gabriel N. Hortobagyi, Ludwig Kiesel, Kenneth Hess, Keith A. Baggerly, Kevin R. Coombes, Lajos Pusztai
Elesclomol, counteracted by Akt survival signaling, enhances the apoptotic effect of chemotherapy drugs in breast cancer cells
Ying Qu, Jinhua Wang, Myung-Shin Sim, Bingya Liu, Armando Giuliano, James Barsoum, Xiaojiang Cui
Cytotoxicity and mechanism of action of a new ROS-generating microsphere formulation for circumventing multidrug resistance in breast cancer cells
Qun Liu, Adam Shuhendler, Ji Cheng, Andrew Michael Rauth, Peter O’Brien, Xiao Yu Wu
Fulvestrant (ICI 182,780) sensitizes breast cancer cells expressing estrogen receptor α to vinblastine and vinorelbine
Meihua Sui, Donghai Jiang, Claire Hinsch, Weimin Fan
Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers
Lindsay A. Brown, Karynn Johnson, Samuel Leung, Tarek A. Bismar, Javier Benítez, William D. Foulkes, David G. Huntsman
A unique RNA-directed nucleoside analog is cytotoxic to breast cancer cells and depletes cyclin E levels
Christine M. Stellrecht, Mary Ayres, Rishi Arya, Varsha Gandhi
Association between tumor tissue TIMP-1 levels and objective response to first-line chemotherapy in metastatic breast cancer
Marie Klintman, Sidse Ørnbjerg Würtz, Ib Jarle Christensen, Pernille Bræmer Hertel, Mårten Fernö, Martin Malmberg, Henning Mouridsen, Frederik Cold, Anne-Sofie Schrohl, John A. Foekens, Per Malmström, Nils Brünner
ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer
Christoph Hirche, Dawid Murawa, Zarah Mohr, Soeren Kneif, Michael Hünerbein
Phase III randomized adjuvant study of tamoxifen alone versus sequential tamoxifen and anastrozole in Japanese postmenopausal women with hormone-responsive breast cancer: N-SAS BC03 study
Tomohiko Aihara, Yuichi Takatsuka, Shozo Ohsumi, Kenjiro Aogi, Yasuo Hozumi, Shigeru Imoto, Hirofumi Mukai, Hiroji Iwata, Toru Watanabe, Chikako Shimizu, Kazuhiko Nakagami, Motoshi Tamura, Toshikazu Ito, Norikazu Masuda, Nobuo Ogino, Kazufumi Hisamatsu, Shoshu Mitsuyama, Hajime Abe, Shiro Tanaka, Takuhiro Yamaguchi, Yasuo Ohashi
Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy
Lori J. Pierce, Kelly-Anne Phillips, Kent A. Griffith, Saundra Buys, David K. Gaffney, Meena S. Moran, Bruce G. Haffty, Merav Ben-David, Bella Kaufman, Judy E. Garber, Sofia D. Merajver, Judith Balmaña, Amichay Meirovitz, Susan M. Domchek
Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancer
Maurizia Mello-Grand, Vijay Singh, Chiara Ghimenti, Maria Scatolini, Lea Regolo, Enrico Grosso, Alberto Zambelli, Gian Antonio Da Prada, Laura Villani, Vittorio Fregoni, Paola Baiardi, Silvia Marsoni, William R. Miller, Alberto Costa, Giovanna Chiorino
Three versus six months of exercise training in breast cancer survivors
Lisa K. Sprod, City C. Hsieh, Reid Hayward, Carole M. Schneider
Changes in the Body Image and Relationship Scale following a one-year strength training trial for breast cancer survivors with or at risk for lymphedema
Rebecca M. Speck, Cynthia R. Gross, Julia M. Hormes, Rehana L. Ahmed, Leslie A. Lytle, Wei-Ting Hwang, Kathryn H. Schmitz
Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasia
Marta Santisteban, Carol Reynolds, Emily G. Barr Fritcher, Marlene H. Frost, Robert A. Vierkant, Stephanie S. Anderson, Amy C. Degnim, Daniel W. Visscher, V. Shane Pankratz, Lynn C. Hartmann
XRCC3 Thr241Met polymorphism and breast cancer risk: a meta-analysis
Konstantinos P. Economopoulos, Theodoros N. Sergentanis
E-cadherin polymorphisms and breast cancer susceptibility: a report from the Shanghai Breast Cancer Study
Alicia Beeghly-Fadiel, Wei Lu, Yu-Tang Gao, Jirong Long, Sandra L. Deming, Qiuyin Cai, Ying Zheng, Xiao-ou Shu, Wei Zheng
Alcohol consumption and breast tumor mitochondrial DNA mutations
Mary E. Platek, Peter G. Shields, Duanjun Tan, Catalin Marian, Matthew R. Bonner, Susan E. McCann, Jing Nie, Gregory E. Wilding, Christine Ambrosone, Amy E. Millen, Maurizio Trevisan, Marcia Russell, Thomas H. Nochajski, Stephen B. Edge, Janet Winston, Jo L. Freudenheim
Coffee and tea intake and risk of breast cancer
Nirmala Bhoo Pathy, Petra Peeters, Carla van Gils, Joline W. J. Beulens, Yolanda van der Graaf, Bas Bueno-de-Mesquita, Awang Bulgiba, Cuno S. P. M. Uiterwaal
Meta-analysis of vitamin D, calcium and the prevention of breast cancer
Peizhan Chen, Pingting Hu, Dong Xie, Ying Qin, Fudi Wang, Hui Wang
The association of metabolic syndrome with triple-negative breast cancer
B. Maiti, M. N. Kundranda, T. P. Spiro, H. A. Daw
Genetic variants in GSTM3 gene within GSTM4-GSTM2-GSTM1-GSTM5-GSTM3 cluster influence breast cancer susceptibility depending on GSTM1
Ke-Da Yu, Lei Fan, Gen-Hong Di, Wen-Tao Yuan, Ying Zheng, Wei Huang, Ao-Xiang Chen, Chen Yang, Jiong Wu, Zhen-Zhou Shen, Zhi-Ming Shao
No evidence for glutathione S-transferases GSTA2, GSTM2, GSTO1, GSTO2, and GSTZ1 in breast cancer risk
Irena E. Andonova, Christina Justenhoven, Stefan Winter, Ute Hamann, Christian Baisch, Sylvia Rabstein, Anne Spickenheuer, Volker Harth, Beate Pesch, Thomas Brüning, Yon-Dschun Ko, Varban Ganev, Hiltrud Brauch
Low SAFB levels are associated with worse outcome in breast cancer patients
Stephanie Hammerich-Hille, Valerie J. Bardout, Susan G. Hilsenbeck, C. Kent Osborne, Steffi Oesterreich
Mitochondrial NADH-dehydrogenase subunit 3 (ND3) polymorphism (A10398G) and sporadic breast cancer in Poland
Anna M. Czarnecka, Tomasz Krawczyk, Marek Zdrożny, Jan Lubiński, Rebecca S. Arnold, Wojciech Kukwa, Anna Ścińska, Paweł Golik, Ewa Bartnik, John A. Petros
Health states of women after conservative surgery and radiation for breast cancer
Gary M. Freedman, Tianyu Li, Penny R. Anderson, Nicos Nicolaou, Andre Konski
Learning to predict relapse in invasive ductal carcinomas based on the subcellular localization of junctional proteins
Nasimeh Asgarian, Xiuying Hu, Zackie Aktary, Kimberly Ann Chapman, Le Lam, Rajni Chibbar, John Mackey, Russ Greiner, Manijeh Pasdar